- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about KZIA
Recent news which mentions KZIA
Stocks That Hit 52-Week Lows On Thursday
October 27, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 27, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 14, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 06, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 10, 2022
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Kazia Therapeutics Shares Jump On Interim Data From Paxalisib Combo Study In Brain Metastases
August 05, 2022
Tickers
KZIA
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 05, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
From Benzinga
From Benzinga
U.S. Stocks Turn Negative; Dow Drops Over 100 Points
August 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 01, 2022
From Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
From Benzinga
U.S. Stocks Turn Higher; Crude Oil Tumbles
August 01, 2022
From Benzinga
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 01, 2022
From Benzinga
From InvestorPlace
Kazia Shares Tumble After Update From Pivotal Brain Tumor Trial
August 01, 2022
Tickers
KZIA
From Benzinga
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
August 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
From Benzinga
From Benzinga
Kazia Therapeutics (KZIA) Stock Soars on FDA Designation
July 06, 2022
From InvestorPlace
From Benzinga
Kazia Shares Shoot Higher As FDA Grants Rare Pediatric Disease Designation To Brain Cancer Candidate
July 06, 2022
Tickers
KZIA
From Benzinga
Stocks That Hit 52-Week Lows On Friday
July 01, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.